https://health-union.com/wp-content/uploads/2025/06/HCP-Connect-Announcement-June2025-NL.png
628
1200
colleen-heavens
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
colleen-heavens2025-09-09 08:34:412025-09-09 08:34:41Health Union Launches HCP Connect: Pioneering a New Era of Community-driven Professional EngagementPeruse Health Union’s latest news announcements on survey findings, awards, leadership, and more. News media interested in learning more about how Health Union can help them tell the health stories they want to tell can visit our Press Kit and Resource Center for News Media.
https://health-union.com/wp-content/uploads/2025/06/HCP-Connect-Announcement-June2025-NL.png
628
1200
colleen-heavens
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
colleen-heavens2025-09-09 08:34:412025-09-09 08:34:41Health Union Launches HCP Connect: Pioneering a New Era of Community-driven Professional Engagement
Health Union Joins Experian’s Data Marketplace: Fueling Health Campaigns with Real-Time Patient and Caregiver Insights

Health Union Launches 2025 Social Health Awards: Elevating Healthcare’s Unsung Voices

Health Union Unveils Innovative 2026 DTC Product Suite, Revolutionizing Patient Engagement with AI and Dynamic Experiences
Health Union Ranks No. 209 on 2019 Deloitte 500™
Health Union has ranked among Deloitte Technology Fast 500 ™ for the second consecutive year due to exponential growth since the company started in 2010.
Survey of Adults with Atopic Dermatitis Symptoms As Kids
84% of survey respondents who experienced atopic dermatitis symptoms as kids said they were diagnosed more than 10 years ago.
Alzheimer’s Disease Caregivers Type and Level of Care
A new Health Union survey finds the experiences of caregivers of people with Alzheimer’s disease differ greatly as the condition progresses.
Likely Indicators of DMT Use Among Multiple Sclerosis Patients
The “Multiple Sclerosis In America 2019” survey uncovers the behaviors of people living with multiple sclerosis using a disease-modifying therapy (DMT).
Contact
1218 Chestnut St., 3rd Floor
Philadelphia, PA 19107
Phone: 484-985-9715
Fax: 484-450-2513
![]()
Privacy Notice
Terms of Use
Your Privacy Choices ![]()
Privacy Rights Request Form
Join Our Team
Press Kit




